Stock 300725 PHARMABLOCK SCIENCES (NANJING), INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages PharmaBlock Sciences (Nanjing), Inc.

Equities

300725

CNE1000035K5

End-of-day quote Shenzhen S.E.
Other stock markets
 23:00:00 25/06/2024 BST 		5-day change 1st Jan Change
28.06 CNY +4.43% Intraday chart for PharmaBlock Sciences (Nanjing), Inc. -3.44% -28.55%
05-30 Tranche Update on PharmaBlock Sciences, Inc.'s Equity Buyback Plan announced on October 31, 2023. CI
05-30 PharmaBlock Sciences, Inc.'s Equity Buyback announced on October 31, 2023, has closed with 836,090 shares, representing 0.42% for CNY 30.03 million. CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
PharmaBlock Sciences, Inc. Announces Dividend on Share A for the Year 2023, Payable on June 14, 2024
PharmaBlock Sciences, Inc. Approves Cash Dividend for the Year 2023
PharmaBlock Proposes Final Dividend for 2023
PharmaBlock Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
PharmaBlock Sciences, Inc Opens HPAPI GMP Facility at Zhejiang Manufacturing Site
PharmaBlock Sciences, Inc. announces an Equity Buyback for CNY 40 million worth of its shares.
PharmaBlock Sciences, Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023
PharmaBlock Sciences, Inc. authorizes a Buyback Plan.
PharmaBlock Sciences, Inc. Reports Earnings Results for the Half Year Ended June 30, 2023
Pharmablock Sciences, Inc. Announces Final Dividend on Share A for 2022, Payable in June 13, 2023
Pharmablock Sciences, Inc. Approves Election of Jie Yuanping and Wu Juanjuan as Non-Independent Directors
Pharmablock Sciences, Inc. Approves Final Cash Dividend for the Year 2022
PharmaBlock Sciences, Inc. Proposes Final Cash Dividend for the Year 2022
PharmaBlock Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
PharmaBlock Opens New R&D Facility in Pennsylvania
PharmaBlock Sciences, Inc. Reports Earnings Results for the Nine Months Ended September 30, 2022
PharmaBlock Sciences, Inc. Reports Earnings Results for the Half Year Ended June 30, 2022
Pharmablock Sciences, Inc. Announces 2021 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on June 13, 2022
PharmaBlock Approves cash dividend for the year of 2021
Pharmablock Sciences, Inc. Proposes Final Cash Dividend for the Year 2021
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 300725 Stock
  4. News PharmaBlock Sciences (Nanjing), Inc.
  5. Other languages